Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

AQSTAQST
13 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in AQUESTIVE THERAPEUTICS INC

Yes. Bank of America holds 1,668,423 shares of AQST (Aquestive Therapeutics), worth $6.9M, as of its Q2 2026 13F filing. It reduced the position by 736,627 shares (-30.6%) from Q1 2026. Bank of America has held AQST since Q4 2023, across 11 quarterly 13F filings.

Current Value

$6.9M

Current Shares

1.7M

Total Value Change

+$6.9M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.7M
-30.6%
$6.9M0.0%$4.16
0
2026-Q1
Increased
2.4M
+99.2%
$10M0.0%$4.15
45
2025-Q4
Decreased
1.2M
-1.2%
$7.8M0.0%$6.46
0
2025-Q3
Decreased
1.2M
-4.8%
$6.8M0.0%$5.59
0
2025-Q2
Decreased
1.3M
-3.6%
$4.2M0.0%$3.31
0
2025-Q1
Increased
1.3M
+92.8%
$3.9M0.0%$2.90
42
2024-Q4
Increased
690,284
+905.2%
$2.5M0.0%$3.56
42
2024-Q3
Decreased
68,670
-70.2%
$341,9770.0%$4.98
0
2024-Q2
Increased
230,154
+918.7%
$598,4000.0%$2.60
39
2024-Q1
Increased
22,593
+159.3%
$96,2460.0%$4.26
24
2023-Q4
New
8,712
-
$17,5990.0%$2.02
28
2023-Q1
Exited
0
-100.0%
$00.0%$1.14
0
2022-Q4
First report
102
-
$920.0%$0.90
0

Other major holders of AQST: BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used